Acute Renal Failure in Different Malignant Tumors

Area of Science:

• Nephrology
• Oncology
• Critical Care Medicine

Background:

• Acute renal failure (ARF) is a critical complication in cancer patients, significantly increasing morbidity and mortality, especially in those requiring renal replacement therapy.
• While ARF pathways in cancer patients overlap with other conditions, specific tumor-related factors and therapies contribute uniquely to renal dysfunction.
• Critically ill cancer patients (CICPs) face a high risk of ARF as part of their overall multi-organ dysfunction.

Purpose of the Study:

• To delineate specific renal disease aspects in CICPs.
• To provide a comprehensive overview of the causes of ARF in CICPs.
• To discuss recent advancements in managing ARF complications in cancer patients, including treatment toxicity and bone marrow transplantation (BMT).

Main Methods:

• Literature review focusing on renal complications in critically ill cancer patients.
• Analysis of factors contributing to ARF in the context of malignancy and its treatment.
• Synthesis of current management strategies and therapeutic interventions for ARF in this population.

Main Results:

• ARF in CICPs is associated with high mortality rates (72-85% for those needing renal replacement therapy).
• Specific tumor characteristics and therapies are identified as unique contributors to ARF.
• Review covers management strategies including addressing treatment toxicity and bone marrow transplantation (BMT).

Conclusions:

• Understanding the specific etiologies of ARF in CICPs is crucial for effective management.
• Proactive prevention and timely intervention are essential to improve outcomes for cancer patients with ARF.
• Further research into novel therapeutic approaches for ARF in CICPs is warranted.